Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring.

Kaoma C, Sathekge M, Chalwe J, Mokoala K, Kgatle M

Open source

DOI
10.3389/fmmed.2026.1852641
Published
2026
Container
Frontiers in molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmmed.2026.1852641,
  title = {Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring.},
  author = {Kaoma C and Sathekge M and Chalwe J and Mokoala K and Kgatle M},
  year = {2026},
  journal = {Frontiers in molecular medicine},
  doi = {10.3389/fmmed.2026.1852641},
  url = {https://doi.org/10.3389/fmmed.2026.1852641}
}

RIS

TY  - JOUR
TI  - Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring.
AU  - Kaoma C
AU  - Sathekge M
AU  - Chalwe J
AU  - Mokoala K
AU  - Kgatle M
PY  - 2026
JO  - Frontiers in molecular medicine
DO  - 10.3389/fmmed.2026.1852641
UR  - https://doi.org/10.3389/fmmed.2026.1852641
ER  - 

APA

C, K., M, S., J, C., K, M., & M, K. (2026). Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring.. Frontiers in molecular medicine. https://doi.org/10.3389/fmmed.2026.1852641

Source records